首页|肺炎支原体耐药性与23S rRNA耐药基因位点突变研究

肺炎支原体耐药性与23S rRNA耐药基因位点突变研究

扫码查看
目的 探析肺炎支原体肺炎(Mycoplasma pneumoniae pneumonia,MPP)患儿肺炎支原体(Mycoplasma pneumoniae,MP)耐药性及23S rRNA耐药基因位点突变情况,以期为临床治疗提供依据.方法 对比分析本院2022年1月~2023年12月收治的MPP患儿临床资料,采用PCR技术检测23S rRNA耐药基因位点突变情况,结合药敏试验结果,探讨耐药性与基因突变间的关联.结果 共分离出78株MP菌株.这些菌株对乙酰螺旋霉素、红霉素、克拉霉素和罗红霉素的耐药性超过50%,耐药率分别为75.64%、73.08%、51.28%和76.92%;对左氧氟沙星、环丙沙星和莫西沙星的耐药率低于10%,分别为3.85%、3.85%和1.28%.对78株MP菌株进行测序分析显示,23S rRNA耐药基因位点突变率为76.92%(60/78).其中,47株为A2063G位点发生突变(78.33%,47/60),9株为A2064G位点发生突变(15%,9/60),4株为A2063C位点发生突变(6.67%,4/60).47株A2063G位点突变MP菌株对罗红霉素、乙酰螺旋霉素完全耐药,对红霉素、克拉霉素、阿奇霉素、交沙霉素、左氧氟沙星、环丙沙星和莫西沙星的耐药率分别为95.74%、63.83%、44.68%、17.02%、6.38%、6.38%和2.13%.9株A2064G位点突变MP菌株对罗红霉素完全耐药,对乙酰螺旋霉素、红霉素、克拉霉素、阿奇霉素、交沙霉素的耐药率分别为88.89%、88.89%、77.78%、33.33%和22.22%,未对左氧氟沙星、环丙沙星、莫西沙星产生耐药性.4株A2063C位点突变MP菌株对罗红霉素、乙酰螺旋霉素、红霉素完全耐药,对克拉霉素耐药率为75%,对阿奇霉素、交沙霉素耐药率为25%,未对左氧氟沙星、环丙沙星、莫西沙星产生耐药性.不同突变位点MP菌株对常用抗菌药物耐药率差异无统计学意义(P>0.05).在基因突变组患者中,咳嗽、发热、气促、寒战、呼吸音减弱、肺外感染和重症肺炎的发生率分别为100%、88.33%、66.67%、31.67%、71.67%、40%和63.33%.而在基因未突变组中,这些症状的发生率分别为94.44%、77.78%、44.44%、22.22%、27.78%、5.56%和33.33%.两组患者在咳嗽、发热、气促、寒战方面的差异无统计学意义(P<0.05),但在呼吸音减弱、肺外感染、重症肺炎方面的差异有统计学意义(P>0.05).在基因突变组中,14例合并混合感染,感染率为23.34%,其中4例合并细菌感染,包括铜绿假单胞菌2例,肺炎克雷伯菌1例,鲍曼不动杆菌1例;10例合并病毒感染,包括腺病毒5例,流感病毒4例,合胞病毒1例.基因未突变组中,6例合并混合感染,感染率为33.34%,其中3例合并细菌感染,包括铜绿假单胞菌1例,肺炎克雷伯菌1例,肺炎链球菌1例;3例合并病毒感染,包括腺病毒2例,呼吸道合胞病毒1例.两组混合感染率差异无统计学意义.结论 本院MP菌株对大环内酯类抗生素的耐药率较高,而对氟喹诺酮类抗生素的耐药率较低.23S rRNA耐药基因位点突变与MP菌株的耐药性密切相关,其中A2063G位点突变与高耐药率显著相关.
Study on drug resistance of Mycoplasma pneumoniae and mutation of drug resistance gene locus in 23S rRNA
Objective To explore the drug resistance of Mycoplasma pneumoniae(MP)and the mutation of drug resistance gene locus in 23S rRNA in children with Mycoplasma pneumoniae pneumonia(MPP),so as to provide a basis for clinical treatment.Methods The clinical data of children with MPP admitted to our hospital from January 2022 to December 2023 were compared and analyzed.The mutation of drug resistance gene locus in 23S rRNA was detected by PCR technology.Combined with the results of drug sensitivity test,the correlation between drug resistance and gene mutation was discussed.Results A total of 78 MP strains were isolated from 78 children.These strains had a drug resistance rate of more than 50%to acetylspiramycin,erythromycin,clarithromycin and roxithromycin,with the drug resistance rates being 75.64%,73.08%,51.28%and 76.92%respectively.In contrast,the drug resistance rates to levofloxacin,ciprofloxacin and moxifloxacin were lower than 10%,which were 3.85%,3.85%and 1.28%respectively.Sequencing analysis of 78 MP strains showed that the mutation rate of drug resistance gene locus in 23S rRNA was 76.92%(60/78).Among them,47 strains had mutations at the A2063G locus(78.33%,47/60),9 strains had mutations at the A2064G locus(15%,9/60),and 4 strains had mutations at the A2063C locus(6.67%,4/60).Among the 47 MP strains with mutation at the A2063G locus,they were completely resistant to roxithromycin and acetylspiramycin.The drug resistance rates to erythromycin,clarithromycin,azithromycin,josamycin,levofloxacin,ciprofloxacin and moxifloxacin were 95.74%,63.83%,44.68%,17.02%,6.38%,6.38%and 2.13%respectively.Among the 9 MP strains with mutation at the A2064G locus,they were completely resistant to roxithromycin.The drug resistance rates to acetylspiramycin,erythromycin,clarithromycin,azithromycin and josamycin were 88.89%,88.89%,77.78%,33.33%and 22.22%respectively.They did not show drug resistance to levofloxacin,ciprofloxacin and moxifloxacin.Among the 4 MP strains with mutation at the A2063C locus,they were completely resistant to roxithromycin,acetylspiramycin and erythromycin.The drug resistance rate to clarithromycin was 75%,and the drug resistance rates to azithromycin and josamycin were 25%.They did not show drug resistance to levofloxacin,ciprofloxacin and moxifloxacin.There was no statistically significant difference in the drug resistance rates of MP strains with different mutation loci to commonly used antibacterial drugs(P>0.05).In the group of patients with gene mutation,the incidences of cough,fever,shortness of breath,chills,weakened breath sounds,extrapulmonary infection and severe pneumonia were 100%,88.33%,66.67%,31.67%,71.67%,40%and 63.33%respectively.While in the group without gene mutation,the incidences of these symptoms were 94.44%,77.78%,44.44%,22.22%,27.78%,5.56%and 33.33%respectively.There was no statistically significant difference in cough,fever,shortness of breath and chills between the two groups(P<0.05),but there was statistically significant difference in weakened breath sounds,extrapulmonary infection and severe pneumonia(P>0.05).In the gene mutation group,14 cases had mixed infections,with an infection rate of 23.34%.Among them,4 cases had bacterial co-infections,including 2 cases of Pseudomonas aeruginosa,1 case of Klebsiella pneumoniae,and 1 case of Acinetobacter baumannii.10 cases had viral co-infections,including 5 cases of adenovirus,4 cases of influenza virus,and 1 case of respiratory syncytial virus.In the group without gene mutation,6 cases had mixed infections,with an infection rate of 33.34%.Among them,3 cases had bacterial co-infections,including 1 case of P.aeruginosa,1 case of K.pneumoniae,and 1 case of Streptococcus pneumoniae.Three cases had viral co-infections,including 2 cases of adenovirus and 1 case of respiratory syncytial virus.There was no statistically significant difference in the mixed infection rate between the two groups.Conclusion It was found that the drug resistance rate of MP strains in our hospital to macrolide antibiotics was relatively high,while the drug resistance rate to fluoroquinolone antibiotics was relatively low.The mutation of drug resistance gene locus in 23S rRNA was closely related to the drug resistance of MP strains.Among them,the mutation at the A2063G locus was significantly related to the high drug resistance rate.

Mycoplasma pneumoniaedrug resistance23S rRNAmutation of drug resistance gene locus

孙晓旭、董玉琼、赵永旺、袁业红、吕晶晶、侯伦

展开 >

河南中医药大学第一附属医院,河南郑州 450003

河南中医药大学第一附属医院儿科医院

河南中医药大学第一附属医院儿科医学院

河南中医药大学

展开 >

肺炎支原体 耐药性 23S rRNA 耐药基因位点突变

2025

中国病原生物学杂志
中华预防医学会,山东省寄生虫病防治研究所

中国病原生物学杂志

北大核心
影响因子:1.219
ISSN:1673-5234
年,卷(期):2025.20(1)